S T Shulman
Overview
Explore the profile of S T Shulman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
202
Citations
2392
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cameron S, White S, Arrollo D, Shulman S, Rowley A
Clin Exp Immunol
. 2017 Jul;
190(2):244-250.
PMID: 28707750
A more complete understanding of immune-mediated damage to the coronary arteries in children with Kawasaki disease (KD) is required for improvements in patient treatment and outcomes. We recently reported the...
2.
Reindel R, Bischof J, Kim K, Orenstein J, Soares M, Baker S, et al.
Clin Exp Immunol
. 2014 Mar;
177(1):203-11.
PMID: 24635044
The major goals of Kawasaki disease (KD) therapy are to reduce inflammation and prevent thrombosis in the coronary arteries (CA), but some children do not respond to currently available non-specific...
3.
Baker S, Shimizu C, Shike H, Garcia F, van der Hoek L, Kuijper T, et al.
Adv Exp Med Biol
. 2006 Oct;
581:523-6.
PMID: 17037590
No abstract available.
4.
Freeman A, Crawford S, Cornwall M, Garcia F, Shulman S, Rowley A
Pediatr Cardiol
. 2005 Sep;
26(5):578-84.
PMID: 16132289
Angiogenesis has been shown to be dysregulated in coronary artery (CA) aneurysms in the chronic phase of Kawasaki disease (KD). Neovascularization may occur in inflammatory-related vascular diseases because many angiogenesis...
5.
Guzman-Cottrill J, Shulman S
Minerva Pediatr
. 2004 Jul;
56(1):51-61.
PMID: 15249914
In the developed world, Kawasaki disease is currently the leading cause of pediatric acquired heart disease. To date, the etiologic agent remains unknown. Many hypotheses regarding the etiology exist, and...
6.
Checchia P, Appel H, Kahn S, Smith F, Shulman S, Pahl E, et al.
Pediatr Crit Care Med
. 2003 Jun;
1(2):146-50.
PMID: 12813266
Objective: Respiratory syncytial virus (RSV) infection is associated with a number of extrapulmonary manifestations, including a sepsis-like syndrome characterized by any combination of hypothermia, fever, apnea, hypovolemia, and myocardial dysfunction....
7.
Freeman A, Shulman S
Curr Opin Infect Dis
. 2002 Apr;
14(3):357-61.
PMID: 11964855
Kawasaki disease is now being recognized as the leading cause of acquired heart disease in children in North America and Japan. This review discusses the recent developments and controversies in...
8.
Gotteiner N, Mavroudis C, Backer C, Pahl E, Duffy C, Dalzell V, et al.
Pediatr Cardiol
. 2002 Apr;
23(1):62-7.
PMID: 11922511
Five patients with a history of Kawasaki disease underwent coronary revascularization at Children's Memorial Hospital (1988-2000). Acute disease occurred at 11 weeks to 5 years of age and revascularization procedures...
9.
Elliott S, Yogev R, Shulman S
Pediatr Neurosurg
. 2001 Oct;
35(3):128-30.
PMID: 11641620
Staphylococcus lugdunensis, a coagulase-negative staphylococcus first described in 1988, has gained recognition as an organism with considerable pathogenic capability in adults. In contrast to the indolent presentation characteristic of other...
10.
Shingadia D, OGorman M, Rowley A, Shulman S
Pediatr Res
. 2001 Sep;
50(4):538-43.
PMID: 11568300
Kawasaki disease (KD) is an acute vasculitis of young childhood predominantly affecting the coronary arteries. IgA plasma cells have been found to infiltrate vascular and nonvascular tissues in fatal acute...